1. Home
  2. PCSA vs OLB Comparison

PCSA vs OLB Comparison

Compare PCSA & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

N/A

Current Price

$2.41

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

N/A

Current Price

$0.57

Market Cap

7.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PCSA
OLB
Founded
2011
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
7.2M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
PCSA
OLB
Price
$2.41
$0.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
39.3K
681.2K
Earning Date
05-07-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,000.00
$12,838,988.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.31
52 Week High
$8.88
$2.50

Technical Indicators

Market Signals
Indicator
PCSA
OLB
Relative Strength Index (RSI) 43.95 44.13
Support Level $0.21 $0.54
Resistance Level $2.56 $0.71
Average True Range (ATR) 0.33 0.05
MACD -0.05 -0.01
Stochastic Oscillator 25.41 14.82

Price Performance

Historical Comparison
PCSA
OLB

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: